key: cord-0334478-0go9f6nh
authors: Burn, Thomas N.; Miot, Charline; Gordon, Scott; Culberson, Erica J.; Diamond, Tamir; Kreiger, Portia; Hayer, Katharina E.; Bhattacharyya, Anamika; Jones, Jessica M.; Bassing, Craig H.; Behrens, Edward M.
title: The RAG1 Ubiquitin Ligase Domain Enhances Assembly and Selection of T Cell Receptor Genes to Restrain the Autoimmune Hazard of Generating T Cell Receptor Diversity
date: 2021-10-14
journal: bioRxiv
DOI: 10.1101/2021.01.04.425211
sha: 2e3925939bef337bbe9bf2646cc76b11f4f43ac2
doc_id: 334478
cord_uid: 0go9f6nh

RAG1/RAG2 (RAG) endonuclease-mediated assembly of diverse lymphocyte antigen receptor genes by V(D)J recombination is critical for the development and immune function of T and B cells. However, this process creates highly self-reactive cells that must be properly selected to suppress autoimmunity. The RAG1 protein contains a ubiquitin ligase domain that stabilizes RAG1 and stimulates RAG endonuclease activity in vitro. We report that mice with a mutation that inactivates the RAG1 ubiquitin ligase in vitro exhibit modestly decreased assembly and altered repertoires of T cell receptor (TCR) β and α genes in thymocytes and impaired thymocyte developmental transitions that require assembly of these genes and signaling by their proteins. The mice also exhibit a combined phenotype of: 1) decreased expression of TCR signaling proteins in thymocytes, 2) less efficient positive selection of conventional αβ T cells and agonist selection of iNKT cells, 3) impaired superantigen-mediated negative selection of highly self-reactive thymocytes, and 4) CD4+ αβ T cells with elevated autoimmune potential. Our findings demonstrate that the RAG1 ubiquitin ligase domain functions in vivo to stimulate TCRβ and TCRα gene assembly and αβ TCR selection, thereby establishing replete αβ TCR diversity and αβ T cell lineages while restraining the inherent autoimmune hazard of creating diverse antigen specificities. Key Points The RAG1 ubiquitin ligase domain stimulates TCR α and β gene assembly in vivo. The RAG1 ubiquitin ligase domain enhances αβ TCR selection of thymocytes. The RAG1 ubiquitin ligase domain limits autoimmune potential of αβ T cells.

RAG1/RAG2 (RAG) endonuclease-mediated assembly of diverse lymphocyte antigen receptor genes by 50 V(D)J recombination is critical for the development and immune function of T and B cells. However, 51 this process creates highly self-reactive cells that must be properly selected to suppress autoimmunity. 52

The RAG1 protein contains a ubiquitin ligase domain that stabilizes RAG1 and stimulates RAG 53 endonuclease activity in vitro. We report that mice with a mutation that inactivates the RAG1 ubiquitin 54 ligase in vitro exhibit modestly decreased assembly and altered repertoires of T cell receptor (TCR) β 55 and α genes in thymocytes and impaired thymocyte developmental transitions that require assembly of 56 these genes and signaling by their proteins. The mice also exhibit a combined phenotype of: 1) 57 decreased expression of TCR signaling proteins in thymocytes, 2) less efficient positive selection of 58 conventional αβ T cells and agonist selection of iNKT cells, 3) impaired superantigen-mediated 59 negative selection of highly self-reactive thymocytes, and 4) CD4 + αβ T cells with elevated autoimmune 60 potential. Our findings demonstrate that the RAG1 ubiquitin ligase domain functions in vivo to stimulate 61 TCRβ and TCRα gene assembly and αβ TCR selection, thereby establishing replete αβ TCR diversity 62 and αβ T cell lineages while restraining the inherent autoimmune hazard of creating diverse antigen 63 specificities. 64 thymocytes, which lack RAG expression and exit the thymus as mature αβ T cells (6-9). Strong TCR 124 signals in DP cells can also activate an alternative agonist selection process that promotes differentiation 125 of unconventional αβ T cell lineages: regulatory T (T reg) cells, intestinal intraepithelial lymphocytes 126 (IELs), and invariant natural killer T (iNKT) cells (6, 7) . Notably, the αβ TCRs of iNKT cells have 127 limited diversity and recognize lipids displayed by MHC-like CD1d proteins on another DP thymocyte 128 (10). This limited diversity renders developing iNKT cells a useful thymocyte population to probe issues 129 of TCR signal strength without confounding by contribution of TCR specificity. 130

The RAG1 protein N-terminus has a Zinc-binding RING finger ubiquitin ligase domain of undetermined 132 relevance for antigen receptor gene assembly. In vitro, RAG1 autoubiquitylates on lysine 233 (11), 133 which enhances RAG endonuclease activity in vitro as evidenced by impaired cleavage upon mutation 134 of this residue (12). In vitro, RAG1 also ubiquitylates other proteins including histone H3 within 135 chromatin (13, 14) . RAG1 RING domain mutations that disrupt ubiquitin ligase activity impair RAG-136 mediated cleavage and joining of chromatin substrates in cell lines, which could be due to loss of histone 137 H3 ubiquitylation and/or alteration in RAG1 protein structure (14-16). The C328Y mutation of a critical 138 structural zinc-binding cysteine of human RAG1 impairs V(D)J recombination and causes severe T and 139 B cell immunodeficiency associated with uncontrolled proliferation of activated oligoclonal αβ T cells 140 (17) . The analogous C325Y mutation of mouse Rag1 protein (C325Y) in vitro destabilizes Rag1 tertiary 141 structure, abrogates ubiquitin ligase activity, reduces V(D) J recombination (22) . Mice with homozygous 142 Rag1 C325Y mutation have a near complete block of αβ T cell development at the DN3 thymocyte 143 stage due to impaired Tcrb recombination (15, 16) . RING domains have a conserved proline (proline 144 326 in mouse Rag1) that is critical for ubiquitin ligase activity by permitting functional interaction with 145 ubiquitin-conjugating enzymes (18, 19) . Relative to C325Y mutation, P326G mutation abrogates Rag1 146 ubiquitin ligase activity equivalently, but has substantially less severe effects on both destabilizing 147 tertiary structure of the Rag1 RING domain and reducing RAG endonuclease activity (16). Accordingly, 148 P326 mutation of endogenous mouse Rag1 protein allows an approach to elucidate potential physiologic 149 roles of the RAG1 ubiquitin ligase domain beyond promoting V(D)J recombination by stabilizing RAG1 150 protein structure. 151

To determine potential in vivo functions of RAG1 ubiquitin ligase activity, we created and analyzed 153 mice carrying a homozygous Rag1 P326G mutation. We show that these mice exhibit decreased levels 154 and altered repertoires of Tcrb or Tcra rearrangements in DN3 or DP thymocytes, respectively, 155 correlating with lower fractions of these cells selected for further differentiation. When assaying αβ 156 TCRs expressing specific TCRβ or TCRα chains, we observe diminished efficiencies for superantigen-157 mediated negative selection of conventional αβ T cells and agonist selection of iNKT cells. We find that 158 the αβ TCR signaled upregulation of CD69 is diminished during initiation of positive selection, and the 159 TCR signaling protein Zap70 is expressed at lower than normal levels in DP cells but not mature αβ T 160 cells. Finally, we show that mature CD4 + effector αβ T cells of these mice exhibit normal immune 161 responses to activation, yet confer greater potential for autoimmunity. Genomic DNA was extracted from DN3 or DP cells using the DNeasy Blood and Tissue kit (Qiagen). 257

To measure Tcrb rearrangements in DN3 cells, a Taqman PCR assay was used to quantify Vβ-to-DJβ1.1 258 and Vβ-to-DJβ2.1 rearrangement levels with a primer specific for each Vβ paired and a probe, FAM or 259 HEX, specific for Jβ1.1 or Jβ2.1, respectively. Taqman PCR was performed with conditions according 260 to the manufacturer's instructions (IDT DNA) on the ViiA 7 system (Applied Biosystems). PCR of 261 CD19 was used for normalization. Primers, probes, and reaction conditions are as described (22). To 262 assay Tcrb repertoire, DNA from DN3 thymocytes were sent to Adaptive Biotechnologies, who used 263 multiplex PCR to amplify and deep sequence Vβ-Dβ-Jβ rearrangements. Gene segment usage was 264 analyzed by ImmunoSEQ Analyzer software (Adaptive Biotechnologies). To assess Tcra 265 rearrangements in DP cells, representative Vα-Jα rearrangements were quantified using a QuantiFast 266 SYBR Green PCR kit (Qiagen) on the ViiA 7 system (Applied Biosystems) as described (23, 24) . PCR 267 of β2M was used for normalization. We quantified Vα14-Jα18 rearrangments as described (25) 

Splenocytes from C57BL/6 background Rag1 -/mice were irradiated with 2,500 Rads (X-rad irradiator) 294 and 3 x 10 5 cells were seeded into each w e l l o f a 9 6 w e l l p l a t e . N a i ve T cells (CD90.2 + , CD4 + , 295 CD62L + , CD44 + , CD25 -) were sorted from C57BL/6 background WT or Rag1 -/mice using a FACSaria 296

Fusion cell sorter (BD Biosciences), and 3 x 10 4 sorted cells were added to each well containing 297 irradiated feeder cells. All cells were cultured with 10 μ g/ml anti-CD3 (Biolegend) and 3 μ g/ml anti-298 CD28 (Biolegend) in RPMI with 10% FBS, 1% PSG, and 1x NEAA (Invitrogen), 1x Sodium Pyruvate 299 (Invitrogen), and 0.001% 2-mercaptoethanol. rhIL-2 was used at 30 IU/mL, rmIL-12 and rmIL-4 at 10 300 ng/mL, rmIL-6 at 20 ng/mL, mTGFβ1 at 1 ng/mL, anti-mIL-4, anti-mIFNγ and anti-mIL-12 at 10 301 μ g/mL (from Biolegend except rhIL-2, rmIL-12, and rmIL-6 from Prepotech). The following 302 cytokines/blocking antibodies were used to skew towards respective Th-subsets: Th0 condition: rhIL-2; 303 Th1 condition: rhIL-2, rmIL-12 and anti-mIL-4; Th2 condition: rhIL-2, rmIL-4, anti-mIFNγ and anti-304 mIL-12; Th17 condition: rhIL-2, mIL-6, mTGFβ1, anti-mIL-4 and anti-mIL-12; Treg condition: rhIL-2, 305 mTGFβ1, anti-mIL-4 and anti-mIL-12. Mice were aged and monitored for disease to a maximum of 30 weeks of age. Mice older than 10 weeks 324 of age were weekly tested for glycosuria (Uristix ® , Siemens). For positive mice, glycosuria was assayed 325 by a second independent test one to three days later depending on the health of the animal. Mice 326 exhibiting glycosuria from two independent readings and deteriorating health were subject to facial vein 327 bleeding for direct measurement of blood glucose levels using an electronic glucose meter. All such 328 mice exhibited a blood glucose concentration of ≥ 250 mg/dL and were considered diabetic and 329 immediately euthanized. 330 331

All data was analyzed in Graphpad Prism 8 using statistical tests indicated in the figure legends. Error 333 bars indicate mean +/-SEM unless otherwise stated. n.s.=p>0.05, *p<0.05, **p<0.01, ***p<0.001, 334 ****p<0.0001. 335

Homozygous Rag1 P326G mutation diminishes TCR gene assembly and subsequent thymocyte 339 developmental stage transitions. 340

To determine potential in vivo functions of the RAG1 ubiquitin ligase, we created and analyzed 341 C57BL/6 strain mice homozygous for the Rag1 P326G mutation (Rag1 P326G/P326G mice; see Materials 342

and Methods) that abrogates RAG1 ubiquitin ligase activity but minimally destabilizes RAG1 protein 343 (16). We initially analyzed αβ T cell development and TCR gene rearrangements in Rag1 P326G/P326G (PG) 344 mice and wild-type (WT) mice. As compared to WT mice, PG mice have a ~2-fold higher percentage 345 and number of DN3 thymocytes and correspondingly lower percentage and number of DN4 thymocytes 346 ( Fig. 1, A and B ). PG mice also exhibit ~10% reductions in the percentage and number of DP 347 thymocytes and the ratio of CD4 + SP thymocytes to DP thymocytes ( Fig. 1 , C-E). Despite these minor 348 impairments of the DN3-to-DN4 and DP-to-SP thymocyte developmental transitions, PG mice have 349 normal numbers of total thymocytes and splenic αβ T cells (Fig. 1 F) and WT mice (Fig. 2 C) , reflecting the modest reduction of Tcrb gene assembly in PG mice. This 358 analysis also reveals modest alterations in Dβ and Jβ usage, but no difference in CDR3β lengths, in Tcrb 359 rearrangements of PG mice (Fig. 2 , D and E; data not shown). Using Taqman PCR to amplify a subset 360 of possible Vα-to-Jα rearrangements in non-selected DP thymocytes, we detected lower levels of 361 rearrangements for many of the Vα/Jα combinations, particularly those involving the two most distal Jα 362 gene segments (Jα17, Jα2) tested, in PG mice (Fig. 2, F) . Together, these data indicate that homozygous 363 Rag1 P326G mutation produces RAG endonuclease complexes that catalyze decreased levels of Tcrb and 364 Tcra rearrangements, alter the primary repertoires of Tcrb and Tcra genes, and support less efficient 365 thymocyte developmental transitions that depend on the functional assembly of a Tcrb or Tcra gene. The 366 lower efficiency of overall Tcrb and Tcra gene assembly certainly contributes to the diminished DN3-to-367 DP and DP-to-SP thymocyte developmental progressions observed in PG mice. 368 369 Notably, the degrees to which TCR gene rearrangements and αβ T cell development are reduced in PG 370 mice are dramatically less severe than reported for homozygous Rag1 C235Y mutation (15). For 371 example, Rag1 P236G mice generate 90% of the normal number of DP thymocytes, whereas homozygous 372 Rag1 C235Y mice produce only 1% of the normal number of DP thymocytes. The markedly different 373 severities of these phenotypes suggest that abrogation of RAG1 ubiquitin ligase activity without 374 substantial disruption of RAG1 protein structure only slightly impairs V(D)J recombination and αβ T 375 cell development. Notably, the Rag1 P326G protein is expressed at modestly higher levels in thymocytes 376 than wild-type Rag1 protein (Beilinson et al., DOI 0.1084/jem.20210250), indicating that reduced Rag1 377 protein expression levels do not contribute to the slightly impaired development of αβ T cells in PG 378 mice. As we were not able to detect Rag1 ubiquitin ligase activity in WT mice, we could not confirm the 379 expected abrogation of Rag1 ubiqutin ligase activity in PG mice that was observed in vitro, leaving open 380 the possibility that the mutant Rag1 P326G protein exhibits some level of ubiquitin ligase activity in vivo. 381

To confirm that the impaired development of αβ T cells in PG mice is due to cell intrinsic properties, we 383 made and analyzed competitive bone marrow chimeric mice. These data show no signficiant differences 384 in contributions of WT cells and PG cells at each of DN thymocyte stages (Supplemental Figure 1A ). In 385 marked contrast, there were greater contributions of WT cells at the DP and both SP thymocyte stages 386 and within the CD4 + and CD8 + splenic αβ T cell populations (Supplemental Figure 1A , B). The data 387 support the notion that the decreased progression of Rag1 P326G thymocytes beyond the DN stage is due to 388 cell intrinsic alterations, most likely from the decreased assembly of TCRβ genes. TCRβ protein to the percentage of these cells that develop into DN3b cells. We found equivalent values 413 between PG and WT mice (Fig. 3, J) . We also compared the percentage of total DN3 cells expressing 414

TCRβ protein to the fraction of these cells that progress to the DN4 stage. Here again we found 415 equivalent values between PG and WT mice (Supplemental Figure 2 ). Together, these data provide no 416 evidence for diminished pre-TCR signaled development of β-selected DN3 thymocytes. Therefore DSBs induced during lymphocyte development signal gene expression changes that persist in mature 431 NK cells lacking RAG1 and RAG2 expression (34). We therefore considered whether the Zap70 432 alterations caused by mutant RAG1 during development would also persist in mature T cells after RAG1 433 is no longer expressed. We detected normal Zap70 protein levels in splenic CD4 + and CD8 + αβ T cells 434 of PG mice (Fig. 4 , F and G), indicating that Rag1 P326G mutation decreases Zap70 expression 435 specifically in immature αβ T cells. These data open the possibility that Zap70-mediated αβ TCR 436 signaling might be weaker than normal in thymocytes and contribute to impaired DP-to-SP thymocyte 437 transition in PG mice, beyond that resulting from reduced Tcra gene assembly and altered primary 438 repertoires of assembled Tcrb and Tcra genes. whether any of these αβ TCR quality control processes might be impaired in PG mice. As a proxy to 447 evaluate positive selection in PG mice, we determined the frequency of αβ TCR expressing (TCRβ + ) 448

Stage 1 thymocytes that initiate positive selection as indicated by progression to Stage 2 in PG and WT 449 mice ( Fig. 5 A) . By analyzing only αβ TCR expressing cells, we circumvent potential effects of 450 decreased Tcra gene rearrangements reducing the fraction of DP thymocytes that express αβ TCRs and 451 are subject to selection. This frequency is lower in PG mice (Fig. 5 B) , consistent with modestly less 452 efficient positive selection of αβ TCR expressing DP thymocytes upon homozygous Rag1 P326G mutation. 453

Yet, we note that this is an imperfect means to quantify positive selection because it cannot account for 454 possible differences in progression through subsequent stages or cellular fate decisions from specific 455 TCR/pMHC interactions. Thus, we also quantified numbers of cells at each of the four stages of positive 456 selection, finding fewer cells at each stage in PG mice relative to WT mice (Fig. 5C) . Importantly, there 457 is a greater decrease of cellularity in stage 2 (1.71x) as compared to stage 1 (1.25x), indicating fewer 458 cells are moving from stage 1 to stage 2 in PG mice. Finally, we quantified CD69 expression and the 459 ratio of CD69 to TCRβ expression at each stage as CD69 upregulation correlates directly with αβ TCR 460 signaling strength. Although we observed no difference of absolute levels of CD69 expression, PG 461 mice have decreased CD69 expression relative to TCRβ expression in stage 2 thymocytes that are 462 initiating positively selection (Fig. 5D) . Collectively, these analyses indicate that αβ TCR signaled 463 upregulation of CD69 and positive selection is less efficient in PG mice. However, they do not 464 distinguish between potential effects from altered primary repertoires of Tcrb and Tcra genes versus 465 diminished intrisinc αβ TCR signaling capacity. They also do not address the possibility that the <10% 466 reduction in numbers of total thymocytes in PG mice alters thymic architecture in a manner that 467 increases the fraction of DP cells that engage pMHC presented by TECs or DCs. 468

To determine whether the Rag1 P326G mutation impairs negative selection , we utilized a naturally 470 occurring system of superantigen-mediated negative selection (38). Laboratory mice express remnant 471 mouse mammary tumor virus (MMTV) retroviral products. Some of these products can bind the MHCII 472 I-E d protein and certain Vβ peptides, including Vβ5.1-5.2 (encoded by Trbv12.1-12.2) and Vβ12 473 (encoded by Trbv15), to trigger exceptionally strong αβ TCR signaling that promotes negative selection 474 (38, 39). Our sequencing analysis of Tcrb gene rearrangements in DN3 thymocytes shows equivalent 475 representation of Trbv12.1, Trbv12.2, and Trbv15 in the primary Vβ repertoire (Fig. 2 C) . Considering 476 that Vβ repertoire remains constant during DN-to-DP thymocyte development (40), assaying 477 superantigen-mediated deletion of Vβ5.1-5.2 or Vβ12 accounts for differences of Jβ repertoire of Tcrb 478 genes assembled in WT and PG mice. Moreover, the reduced level and altered repertoire of Tcra genes 479 assembled in DP cells of PG mice would not influence superantigen-mediated deletion of thymocytes 480 expressing αβ TCRs with specific Vβ peptides. BALB/c, but not C57BL/6, strain mice express I-E d 481

protein. As a result, thymocytes expressing Vβ5.1-5.2 or Vβ12 are efficiently deleted in BALB/c, but 482 not B6, genetic backgrounds. We bred BALB/c background Rag1 -/mice with C57BL/6 background 483 Rag1 PG or WT mice to generate and analyze Rag1 PG/and Rag1 WT/mice expressing I-E d protein.

To 484 ascertain whether these mice exhibit a difference in superantigen-mediated negative selection, we 485 measured the frequencies of DP thymocytes that have not completed αβ TCR selection and post-486 selection SP thymocytes expressing I-E d :MMTV-reactive (Vβ5 + or Vβ12 + ) or -unreactive (Vβ6 + , Vβ8 + , 487 or Vβ14 + encoded by Trbv19, Trbv13.1-13.3, or Trbv31, respectively) αβ TCRs (Fig. 6 , A-F). We 488 calculated the percentages of DP and SP thymocytes expressing each Vβ peptide (Fig. 6 , B-F). Our 489 analysis indicates that greater fractions of I-E d :MMTV-reactive thymocytes proceed through DP-to-SP 490 development in Rag1 PG/mice as compared to Rag1 WT/mice (Fig. 5, B , C, and G), consistent with 491 impaired negative selection of highly self-reactive thymocytes. In contrast, we found that the types of 492 un-reactive thymocytes assayed develop equivalently in each genotype (Fig. 5, D -G) . While the latter 493 finding does not reflect less efficient positive selection, we note that this experiment monitors a small 494 subset of thymocytes expressing specific Vβ peptides and thus is not as sensitive as determining the 495 frequencies of overall DP thymocytes that initiate positive selection. Regardless, the data indicate that 496 PG mice exhibit less efficient deletion of thymocytes that express αβ TCRs containing superantigen-497 reactive Vβ peptides. The plausible reasons for this impaired form of negative selection include that 498 intrinsic αβ TCR signaling capacity is dampened and/or reduced numbers of DP thymocytes prevents 499 some from contacting or maintaining interaction with superantigen. 500 501 Finally, to ascertain potential effects of Rag1 P326G mutation on agonist selection, we focused on assaying 502

iNKT cell development. This lineage develops when TCRs containing an invariant Vα14-Jα18 TCRα 503 chain and TCRβ chains with Vβ regions encoded by Trbv1, Trbv13.1-13.3 , or Trbv19 bind lipids 504 presented by the MHC-like CD1d protein on different DP thymocytes (10, 41, 42). These interactions 505 induce strong TCR signals that drive agonist selection and differentiation of iNKT cells through distinct 506 stages that can be identified by binding lipid/tetramers and expression of defined proteins (10, 41, 42) . 507

We first used a CD1d tetramer loaded with PBS57, an analogue of the α-galactosylceramide (α-GalCer) 508 glycolipid, to identify α-GalCer-reactive iNKT cells in WT and PG mice. As compared to WT mice, PG 509 mice had fewer absolute numbers of thymic α-GalCer-reactive iNKT cells (Fig. 7, A and B) . While PG 510 mice also tended to have fewer splenic iNKT cells (Fig. 7, A and B) , this difference did not reach 511 statistical significance (p=0.06) with the numbers of mice analyzed. The lower number of thymic iNKT 512 cells in PG mice could arise solely from decreased levels of Tcra rearrangements, as is observed by 513 other mutations that decrease these rearrangements over an order of magnitude (43, 44) . The levels of 514

Vα14-to-Jα18 rearrangements in total thymocytes of PG mice are ~40% relative to WT mice (Fig. 7C) , 515 which is consistent with reduced generation of Vα14-Jα18 TCRα chains contributing to the lower 516 numbers of thymic α-GalCer-reactive iNKT cells in PG mice. However, one advantage of using 517 tetramers is that they identify DP thymocytes that have assembled and express the appropriate Tcrb and 518

Tcra genes for development into iNKT cells of defined antigen specificity. Thus, as a means to quantify 519 agonist selection of α-GalCer-reactive iNKT cells independent of Vα14-Jα18 recombination levels, we 520 quantified tetramer-staining cells at each stage of iNKT cell development. We observed no significant 521 differences in numbers of Stage 0 (CD24 hi CD44 − NK1.1 − ) and Stage 1 (CD24 lo CD44 − NK1.1 − ) iNKT 522 cells in WT and PG mice (Fig. 7, D and E) . However, PG mice had lower numbers of Stage 2 523 (CD24 lo CD44 + NK1.1 − ) and Stage 3 (CD24 lo CD44 + NK1.1 + ) iNKT cells (Fig. 7, D and E) and 524 diminished expansion of iNKT cells during progression from Stage 0 through Stage 4 (Fig. 7, F) . 525

Notably, the median fluorescence intensities of TCRβ expression and PBS57/CD1d tetramer binding of 526 thymocytes was similar or slightly higher in PG mice relative to WT mice ( Fig. 7 A, data not shown) , 527

indicating that α-GalCer-reactive iNKT cells of PG mice have a normal range of intrinsic affinity for 528 this lipid presented by CD1d. Therefore, the plausible reasons for the impaired development of α-529

GalCer-reactive iNKT cells in PG mice are diminished engagements of TCRs with lipid/CD1d 530 complexes and/or TCR signaling following lipid/CD1d recognition. We also analyzed iNKT 531 development in the competitive setting of mixed bone marrow chimeras comparing mice that received 532 donor bone marrow that was either 100% PG or at 1:1 mix of PG and WT marrow. The very few 533 remnant WT cells in the 100% PG receipient mice very effectively outcompeted the PG cells starting at 534

Stage 1 and increasing in later stages (Supplemental Figure 1, C) . The same effect can be seen in the 1:1 535 mix recipient mice (Supplemental Figure 1, C) . Thus, these data indicate that the impaired iNKT cell 536 development in PG mice is cell intrinsic, making impaired TCR signaling the most plausible explanation. 537

The molecular basis for impaired TCR signaling could be reduced expression of Zap70 and/or other 538 signaling proteins, altered TCRβ CDR3-encoding sequences that generate TCRs less effective at 539 signaling upon recognition of lipids presented by CD1d, or both. 540 541 Mature αβ T cells of homozygous Rag1 P326G mice exhibit normal responses to activation. 542 RAG endonuclease activity during lymphocyte ontogeny triggers permanent changes in gene expression 543 that correlate with impaired responses of mature lymphocytes (34). Considering that RAG endonuclease 544 function is diminished in thymocytes of PG mice, we sought to elucidate whether the mature αβ T cells 545 of these animals have normal or altered response to activation. We first conducted in vitro analyses. 546

Upon stimulation with PMA and ionomycin, splenic CD44 hi αβ T cells from PG mice produce normal 547 levels of IFNγ, TNFα, IL-2, and IL-17A (Fig. 8 A) . These cells also show normal proliferation upon 548 anti-CD3/anti-CD28 stimulation (Fig. 8 B) . Moreover, stimulated CD4 + and CD8 + αβ T cells of PG 549 mice normally express their canonical transcription factors (Fig. 8 , C and D) and cytokines (Fig. 8, E  550 and F) when cultured in respective skewing conditions. We next monitored αβ T cell responses in vivo 551 following infection of mice with an acute strain of lymphocytic choriomeningitis virus (LCMV-552 Armstrong). We analyzed mice either seven days later to monitor at the immune response peak or 35 553 days later to monitor memory cells. At each timepoint, we detected similar frequencies and numbers of 554 antigen-specific CD8 + αβ T cells that stain with gp33:H-2Db tetramer in PG and WT mice (Fig. 8 G) , 555

indicating that PG mice display normal numbers and dynamic responses of αβ T cells that recognize 556 LCMV-Armstrong. We also observed equivalent dynamic expression of Tbet, Eomes, KLRG1, and 557 CD127 proteins on αβ T cells from PG and WT mice (Fig. 8 H) , indicating normal contraction of short-558 lived effector cells (SLECs), and sustained memory/memory precursor effector cells (MPECs) in PG 559 mice. Finally, we detected similar numbers of antigen specific αβ T cells able to respond to the gp33, 560 NP396, or gp61 viral peptides within a peptide re-stimulation assay (Fig. 8, I and J ). Together, these data 561 demonstrate that the mature αβ T cells of PG mice have normal responses to activation, at least for the 562 stimuli assayed. 563 564

Within a setting of less efficient negative selection as with homozygous Rag1 P326G mutation, an 567 increased predisposition to αβ T cell mediated autoimmunity would be expected. However, we did not 568 observe overt autoimmune symptoms within PG mice, possibly because mice of the C57BL/6 569 background are resistant to spontaneous autoimmune diseases (45, 46). Thus, to investigate whether the 570 Rag1 P326G mutation can predispose to autoimmunity, we utilized an induced model of autoimmune 571 colitis in C57BL/6 mice and a spontaneous model of autoimmune diabetes in NOD mice. 572 573 The colitis model involves transferring into Rag1 -/mice naïve CD4 + effector αβ T cells, which become 574 activated and trigger cytokine-driven colitis and associated systemic pathologies including weight loss 575 due to the absence of Tregs (26, 47, 48). We observed accelerated wasting of Rag1 -/mice receiving PG 576 cells relative to WT cells or no transfer (Fig. 9 A) . We analyzed mice at eight weeks after transfer. As 577 compared to WT recipients, we detected greater numbers of total splenic CD4 + T cells and of CD4 + T 578 cells producing IFNγ, TNFα, and/or GM-CSF cytokines (Fig. 9, B and C) . Colon length is used as a 579 measure of disease severity in this model, and mice receiving transferred PG cells had shorter colons 580 relative to mice receiving WT cells, consistent with worse disease caused by PG cells (Fig. 9 D) . 581

Histologic assessment and scoring in this colitis model has been formalized (48), and can be grossly 582 broken down into scores related to inflammatory cell infiltration and scores related to injury of tissue 583 architecture. There was no statistical difference in inflammation scores between mice receiving WT and 584 PG cells. However, tissue damage scores were higher in mice receiving PG cells, suggesting that, on a 585 per cell basis, PG cells induce greater tissue injury in this model (Fig. 9, E-F) . Notably, specifically in 586 PG-transferred animals, we observed autoimmune pathologies in addition to colitis, including dermatitis, 587 chylous ascites, severe small intestine enlargement, and neurological stress (Fig. 9 H) . Dermatitis was 588 most common and involved massive inflammatory infiltration and tissue damage (Fig. 9 I) . Consistent 589 with more widespread autoimmune conditions in PG-transferred mice, we significant splenomegaly in 590 these mice (Fig. 9 J) . Finally, while not statistically significant, we observed an increased rate of 591 premature death in the mice transferred with PG cells compared to WT cells ( Fig. 9 K) , which was 592 especially surprising because death is an unexpected outcome in this model. Collectively, the data from 593 this colitis model indicate that CD4 + effector T cells from PG mice have greater than normal intrinsic 594 autoimmune potential. 595 596 For the spontaneous model of autoimmune diabetes, we utilized CRISPR/Cas9-mediated gene editing to 597 establish NOD mice carrying the Rag1 P326G mutation. NOD mice develop spontaneous αβ T cell driven 598 diabetes at an incidence of 60-80% in females and 20-30% in males (49, 50). We bred together 599 NOD:Rag1 P326G/WT mice to create cohorts of NOD PG and WT females, which we aged and screened for 600 diabetes by monitoring glycosuria and blood glucose levels, euthanizing diabetic mice and confirming 601 disease by blood glucose levels. We observed accelerated onset of diabetes in PG mice compared to WT 602 mice, with median age of disease-free survival 120 and 175 days, respectively (Fig. 9 L) . We started this 603 study with the assumption that NOD Rag1 P326G mice will experience an early event due to autoimmunity 604 risk as compared to NOD Rag1 WT mice, and if events do not occur early then they are unlikely to occur 605 at all. Therefore, we evaluated potential significance of the different median disease-free survival using 606 the Gehan-Breslow-Wilcoxon test that models such un-proportional hazard, finding the difference 607 significant (p=0.049). However, we also applied the long-rank Mantel-Cox test that is more stringent, 608 but should be used when the assumption is of proportional hazards between groups, finding the 609 difference near, but not reaching, significance (p=0.1151). Unfortunately, the disruption of research 610 from the Covid19 pandemic prevented us from continuing to generate and monitor mice so that we 611 could more rigorously evaluate the difference in diabetes-free survival, as well as pathologically and 612 immunologically characterize disease in afflicted mice. Finally, we note that this experiment does not 613 distinguish between potential abnormalities of T and B cells of the PG background. Tcrb gene rearrangements of PG mice could generate αβ TCRs less effective at signaling upon 663 recognition of lipid/CD1d complexes, leading to impaired iNKT cell development. The higher 664 autoimmune potential of αβ T cells in PG mice most likely results from impaired negative selection of 665 high self-reactive thymocytes. In mice with normal RAG endonuclease activity, highly self-reactive αβ 666 TCRs signal negative selection by apoptosis before further Tcra gene recombination can replace these 667 hazardous receptors with new ones (51). The reduced levels of Tcra gene rearrangements in PG mice 668 would be expected to increase the likelihood that negatively-selecting TCRs remain expressed and 669 trigger apopotisis. Considering all of the above, the most plausible reasons for less efficient negative 670 selection, impaired iNKT cell development, and higher autoimmune potential of CD4 + T cells in PG 671 mice are: 1) less robust TCR signaling upon recognition of self-antigens, and/or 2) decreased 672 frequencies or durations that αβ TCRs engage self-antigens due to the 50% fewer DP thymocyes and 673 potentially altered thymic microenvironment. Our mixed bone marrow chimera analysis indicates that 674 such cell extrinsic mechanisms cannot explain impaired agonist selection of α-GalCer-reactive iNKT 675 cells, leaving decreased αβ TCR signaling as a plausible mechanism. Genetic mutations in mice that 676 substantially impair V(D)J recombination also dramatically (>10-fold) reduce thymic cellularity and 677 consequently alter thymic architecture through defective maturation of TECs and/or distribution of DCs, 678 which collectively impairs negative selection and increases development of hazardous autoreactive αβ T 679 cells (52). Although the slightly lower than normal levels of TCR gene rearrangements in PG mice 680 cause only a minor decrease in DP thymocyte cellularity, it will be important to determine if the 681 Rag1 P326G mutation has any effects on the thymic microenvironment that could underlie less efficient 682 negative selection. 683

The lower than normal expression of Zap70 protein specifically in thymocytes of PG mice offers 685 support and a potential basis for impaired αβ TCR signaling contributing to less efficient thymocyte 686 selection. As reduced Zap70 activity impairs TCR signaling, positive selection, negative selection, and 687 agonist selection of iNKT cells (53-55), attenuated TCR signaling from lower Zap70 expression, even 688 the subtle decrease observed, is a plausible explanation for these phenotypes of PG mice. However, 689 definitive conclusions necessitate elucidating how Rag1 P326G mutation decreases Zap70 protein levels 690 and determining effects of disrupting these mechanisms without lowering RAG endonuclease activity. 691 RAG DSBs induced during Igκ gene recombination in pre-B cells activate diverse signaling pathways 692 that transcriptionally alter the expression of several antigen receptor signaling proteins to diminish pre-693 BCR signaling (31, 56). Thus, it is conceivable that RAG DSBs induced during Tcra gene 694 rearrangements in DP thymocytes could trigger nucleus-to-cytoplasm signaling cascades that post-695 transcriptionally increase Zap70 protein expression. In this scenario, the decreased number of RAG 696

DSBs generated during Tcra gene rearrangements in PG DP thymocytes might impair activation of such 697 signals. A not-mutally exclusive possibility is that Rag1 P326G mutation prevents the Rag1-directed 698 ubiquitylation of nuclear proteins that amplify the signals from RAG DSBs that up-regulate Zap70 699 protein expression. Another possibility is that integrity of the Rag1 ubiqutin ligase domain is necessary 700 for binding a factor the influences signals from RAG DSBs. We did not detect differences in Zap70 701 activation or other aspects of TCR signaling between WT and PG thymocytes after anti-CD3 stimulation 702 (data not shown). However, this approach for activating aβ TCR signaling is not as sensitive for 703 detecting differences as using tetramers or DCs to present peptides to transgenic αβ TCRs of fixed 704 specificity (9, 57, 58). Such experiments, which are beyond the scope of our current study, are critical to 705 determine whether Rag1 P326G mutation diminishes αβ TCR signaling spefiically in DP thymocytes. 706

Considering that Zap70 might not be the only, or even a relevant, TCR signaling protein affected by this 707 Rag1 mutation, findings that confirm diminished TCR signaling would warrant identifying all changes 708 in thymocyte protein expression triggered by RAG DSBs and elucidating the effect of Rag1 P326G 709 mutation on these. This information would suggest approaches to disrupt signaling from RAG DSBs 710 without reducing RAG endonuclease activity to separate impacts of Rag1 P326G mutation on altering 711 expression of TCR signaling proteins versus reducing Tcrb and Tcra gene rearrangements, altering 712 assembled Tcrb and Tcra gene repertoires, and decreasing thymic cellularity. 713

The requirement for TCR selection on self-peptides displayed by self-proteins presents major challenges 715 for establishing conventional and non-conventional αβ T cell populations that recognize and respond to 716 a vast array of diverse foreign peptides, but not self-antigens. Thus, cell intrinsic mechanisms, at least 717 some of which are Rag1-independent, have evolved to render thymocytes more sensitive to TCR 718 stimulation than their mature αβ T cell counterparts (57, (59) (60) (61) (62) 

T r β v 5 T r β v 1 2 -1 T r β v 1 2 -2 T r β v 1 3 -1 T r β v 1 3 -2 T r β v 1 3 -3 T r β v 1 4 T r β v 1 5 T r β v 1 6 T r β v 1 7 T r β v 1 9 T r β v 2 0 T r β v 2 3 T r β v 2 4 T r β v 2 6 T r β v 2 9 T r β v 3 0 T r β v 3 1 VDJ2 rearrangements (c.f. CD19) Figure 8 

The mechanism and regulation of chromosomal 737 V(D)J recombination

V(D)J recombination: mechanisms of initiation

Commitment and 741 developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from

Checkpoints in lymphocyte development and 744 autoimmune disease

Chromatin Dynamics and the Development of the 746 TCRalpha and TCRdelta Repertoires

The self-obsession of T cells: how TCR signaling 748 thresholds affect fate 'decisions' and effector function

TCR Signal Strength and T Cell 750 Development

Positive and negative selection of 752 the T cell repertoire: what thymocytes see (and don't see)

Fine-tuning T 754 cell receptor signaling to control T cell development

Invariant Natural Killer T Cell Subsets-More Than Just 756 Developmental Intermediates

Autoubiquitylation of the V(D)J recombinase protein RAG1

Role of RAG1 autoubiquitination in V(D)J recombination

The 762 RAG1 V(D)J recombinase/ubiquitin ligase promotes ubiquitylation of acetylated

The RING 765 domain of RAG1 ubiquitylates histone H3: a novel activity in chromatin-mediated regulation of 766 V(D)J joining

RAG1-mediated ubiquitylation of histone H3 is required for 768 chromosomal V(D)J recombination

Biochemical and folding defects 770 in a RAG1 variant associated with Omenn syndrome

V(D)J recombination defects 776 in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical 777 presentations

Structure of a c-Cbl-UbcH7 779 complex: RING domain function in ubiquitin-protein ligases

Identification of a ubiquitin-protein ligase subunit within 782 the CCR4-NOT transcription repressor complex

A cre-transgenic mouse strain for the ubiquitous 784 deletion of loxP-flanked gene segments including deletion in germ cells

Two Successive Inversional Vbeta Rearrangements on a 787 Single Tcrb Allele Can Contribute to the TCRbeta Repertoire

Unifying model for 790 molecular determinants of the preselection Vbeta repertoire

Tcra gene recombination is supported by a Tcra enhancer-and CTCF-dependent chromatin hub

A discrete chromatin loop in the 796 mouse Tcra-Tcrd locus shapes the TCRdelta and TCRalpha repertoires

NKT cells derive from double-799 positive thymocytes that are positively selected by CD1d

T cell transfer model of chronic colitis: concepts, 802 considerations, and tricks of the trade

The 804 "dispensable" portion of RAG2 is necessary for efficient V-to-DJ rearrangement during B and T 805 cell development

Noncore RAG1 regions promote Vbeta rearrangements 807 and alphabeta T cell development by overcoming inherent inefficiency of Vbeta recombination 808 signal sequences

A new look at Syk in alpha beta and gamma delta T cell development using 811 chimeric mice with a low competitive hematopoietic environment

Distinct roles for Syk and ZAP-70 during early thymocyte 813 development

RAG-mediated DNA double-strand breaks activate a cell type-specific 817 checkpoint to inhibit pre-B cell receptor signals

Regulated costimulation in the thymus is critical for T cell development: 820 dysregulated CD28 costimulation can bypass the pre-TCR checkpoint

Timing and duration of MHC I positive selection signals are 824 adjusted in the thymus to prevent lineage errors

The RAG recombinase dictates functional 826 heterogeneity and cellular fitness in natural killer cells

RAG-induced DNA double-strand breaks signal through Pim2 to promote pre-B cell 829 survival and limit proliferation

A hypomorphic allele of ZAP-879 70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity

DNA double-strand 884 breaks activate a multi-functional genetic program in developing lymphocytes

Preselection thymocytes are more sensitive to T cell receptor stimulation than mature T 888 cells

Themis sets the signal threshold for 891 positive and negative selection in T-cell development

Divergent changes 893 in the sensitivity of maturing T cells to structurally related ligands underlies formation of a 894 useful T cell repertoire

T cell activation enhancement by 896 endogenous pMHC acts for both weak and strong agonists but varies with differentiation state

Lower 899 receptor avidity required for thymic clonal deletion than for effector T-cell function

Negative selection of thymocytes expressing 902 the D10 TCR

Themis controls thymocyte selection through regulation of T cell antigen 906 receptor-mediated signaling

Themis, a T cell-specific protein important 909 for late thymocyte development

Themis is a member of a new metazoan gene family and is 913 required for the completion of thymocyte positive selection

Tespa1 is involved in late 916 thymocyte development through the regulation of TCR-mediated signaling

miR-181a is an intrinsic 920 modulator of T cell sensitivity and selection

Scored as per previously 1063 described guidelines for the five phenotypes (48): (F) Colon inflammation score (contribution of scores 1064 for crypt abcesses and inflammatory cell infiltrate). (G) Colon tissue damage score (contribition of 1065 scores for crypt architecture, tissue damage, goblet cell loss). (H) Non-colitis pathologies described for 1066 mice transferred with WT versus PG cells. (I) Hemotoxylin and eosin stained skin section from PG-1067 transferred mouse with severe dermatitis at eight weeks post-transfer. 10x magnification. (J) Spleen 1068 weight at eight weeks post-transfer normalized to total mouse bodyweight prior to transfer. (K) Survival 1069 curves of mice

Shown are all data points from three 1072 independent experiments, 12-14 mice per group. Experiment indicated by shape of data point. Bar 1073 indicates global mean. Analyzed by 2-way ANOVA with Tukey HSD post-test

0001 (L) Curves showing diabetes free survival of female NOD WT 1075 (n=16) and PG (n=14) mice. Mice were generated by mating together NOD Rag1 WT/PG mice and 1076 monitored for their first 30 weeks of life. The percent diabetes survival curves include mice that have 1077 passed 20 weeks of age or gotten diabetes before 20 weeks of age

Wilcoxon test (p=0.049) and log-rank Mantel Cox test (p=0.1151)

T r v 1 2 -1 T r v 1 2 -2 T r v 1 2 -3 T r v 1 3 -1 T r v 1 3 -2 T r v 1 3 -3 T r v 1 4 T r v 1 5 T r v 1 6 T r v 1 7 T r v 1 9 T r v 2 0 T r v 2 1 T r v 2 2 T r v 2 3 T r v 2 4 T r v 2 6 T r v 2 7 T r v 2 9 T r v 3 0 T r v 3 1 10% 8% 6% 4% 2% 0% % of in-frame rearraggements **** **** T r j 1 -1 T r j 1 -2 T r j 1 -3 T r j 1 -4 T r j 1 -5 T r j 1 -6 T r j 1 -7 T r j 2 T r j 2 -1 T r j 2 -2 T r j 2 -3 T r j 2 -4 T r j 2 -5 T r j 2 -6 T r j 2 -7 0 5 10 15 20 25